gms | German Medical Science

24th Annual Meeting of the German Retina Society

German Retina Society

17.06. - 18.06.2011, Aachen

Perioperative anti-VEGF administration in the pars plana vitrectomy (PPV) of the diabetic eye

Meeting Abstract

Search Medline for

  • Jörg C. Schmidt - Augenklinik Tausendfensterhaus, Duisburg
  • S. Mennel - Universitäts-Augenklinik Marburg

German Retina Society. 24th Annual Conference of the German Retina Society. Aachen, 17.-18.06.2011. Düsseldorf: German Medical Science GMS Publishing House; 2011. Doc11rg40

doi: 10.3205/11rg40, urn:nbn:de:0183-11rg402

This is the English version of the article.
The German version can be found at: http://www.egms.de/de/meetings/rg2011/11rg40.shtml

Published: June 15, 2011

© 2011 Schmidt et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Background: In diabetic patients with progressive proliferative retinopathy and macular edema a pars plana vitrectomy is necessary.

Materials and methods: In vitrectomies in diabetic eyes, there are often massive proliferative changes in both the retina and the iris. Intraoperative and postoperative bleeding are common.

Results: The intravitreal administration of anti-VEGF few days before the PPV reduces the congestion of the retinal vasoproliferationen and the iris. This makes it easy to remove membranes en bloc. A air-endotamponade further reduces the postoperative bleeding.

Conclusion: In patients with impaired Iristrophik and barrier disorders like diabetes the surgical procedure can be greatly simplified by the use of anti-VEGF. A hämostypische tamponade with silicone oil is usually not required and macular edema is treated with.